Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - ALBIREO PHARMA, INC. | albo-20210331xex31d2.htm |
| EX-31.1 - EX-31.1 - ALBIREO PHARMA, INC. | albo-20210331xex31d1.htm |
| EX-10.1 - EX-10.1 - ALBIREO PHARMA, INC. | albo-20210331xex10d1.htm |
| 10-Q - 10-Q - ALBIREO PHARMA, INC. | albo-20210331x10q.htm |
Exhibit 32.1
CERTIFICATIONS UNDER SECTION 906
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Albireo Pharma, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Quarterly Report for the quarter ended March 31, 2021 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: May 6, 2021 | | /s/ Ronald H.W. Cooper |
| | Ronald H.W. Cooper |
| | President and Chief Executive Officer |
| | (principal executive officer) |
Dated: May 6, 2021 | | /s/ Simon Harford |
| | Simon N.R. Harford |
| | Chief Financial Officer and Treasurer |
| | (principal financial officer and principal accounting officer) |